Hudson Bay Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Hudson Bay Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77,500	Closed	-$2.33M	–	1475
2026 Q1	$2.33M	Sell	77,500 -92,500	-54%	-$3.06M	0.01%	731
2025 Q4	$5.56M	Sell	170,000 -75,000	-31%	-$2.42M	0.02%	475
2025 Q3	$8.49M	Sell	245,000 -270,000	-52%	-$8.64M	0.03%	399
2025 Q2	$14.4M	Sell	515,000 -50,000	-9%	-$1.34M	0.05%	274
2025 Q1	$14.2M	Buy	565,000 +10,700	+2%	+$270K	0.04%	322
2024 Q4	$15.2M	Buy	554,300 +44,300	+9%	+$1.23M	0.05%	280
2024 Q3	$14.7M	Sell	510,000 -15,000	-3%	-$408K	0.06%	212
2024 Q2	$13M	Buy	525,000 +92,600	+21%	+$2.63M	0.06%	190
2024 Q1	$13.9M	Buy	432,400 +100,400	+30%	+$3.73M	0.08%	142
2023 Q4	$13.5M	Sell	332,000 -18,000	-5%	-$662K	0.09%	141
2023 Q3	$12.1M	Buy	350,000 +25,000	+8%	+$973K	0.1%	140
2023 Q2	$13.2M	Sell	325,000 -7,500	-2%	-$306K	0.1%	141
2023 Q1	$12.8M	Buy	332,500 +20,000	+6%	+$822K	0.11%	141
2022 Q4	$13.9M	Sell	312,500 -10,000	-3%	-$421K	0.14%	125
2022 Q3	$13.8M	Buy	322,500 +106,000	+49%	+$5.43M	0.12%	113
2022 Q2	$12.1M	Buy	216,500 +184,000	+566%	+$10.9M	0.09%	147
2022 Q1	$2.02M	Sell	32,500 -112,500	-78%	-$6.89M	0.03%	688
2021 Q4	$7.99M	Sell	145,000 -10,000	-6%	-$522K	0.08%	188
2021 Q3	$8.15M	Buy	155,000 +30,000	+24%	+$1.78M	0.11%	186
2021 Q2	$8.61M	Buy	125,000 +67,500	+117%	+$5.15M	0.1%	171
2021 Q1	$4.43M	Buy	+57,500	New	+$5.3M	0.05%	333
2018 Q2	–	Sell	-13,700	Closed	-$1.37M	–	868
2018 Q1	$1.37M	Buy	+13,700	New	+$1.48M	0.03%	521
2017 Q3	–	Sell	-20,000	Closed	-$1.53M	–	443
2017 Q2	$1.53M	Buy	+20,000	New	+$1.68M	0.03%	376

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Hudson Bay Capital Management's LKFT Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 77,500 shares — an estimated $2.33M sold.

Hudson Bay Capital Management first reported a position in LKFT in Q2 2017 and held it in 23 quarters. The position peaked at $15.2M in Q4 2024. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Hudson Bay Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 77,500 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $2.33M.
Hudson Bay Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 23 quarters.
Hudson Bay Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $15.2M in Q4 2024.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.